Antibodies against oxidized low-density lipoprotein in normolipidemic smokers - 02/09/11
Doi : 10.1016/S0002-9149(02)02576-6
Á.gueda Zaratin, PhD a, Magnus Gidlund, PhD b, Paulo Boschcov, PhD c, L.úcia Castilho, PhD a, Eliana Cotta de Faria, MD, PhD a, ⁎ 
a Department of Clinical Pathology, NMCE, UNICAMP, Campinas, São Paulo, Brazil
b Laboratory of Immunophysiopathology, ICB-USP and IMT-SP, São Paulo, São Paulo, Brazil
c Department of Biophysics, Federal University of São Paulo, São Paulo, Brazil
*Dr. Cotta de Faria’s address is: Department of Clinical Pathology, Faculty of Medical Sciences, University of Campinas, Caixa Postal 6111, CEP 13083-970, Campinas SP, Brazil.
 | This study was supported in part by Grants 99/00158-4 and 99/07446-5 from the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), and the Conselho Nacional de Pesquisa (CNPq), São Paulo, Brazil. |
© 2002
Excerpta Medica Inc. Tous droits réservés.
Vol 90 - N° 6
P. 651-653 - septembre 2002 Retour au numéro
Article précédent
- Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia
- Graziana Lupattelli, Simona Marchesi, Anna Rita Roscini, Donatella Siepi, Fabio Gemelli, Matteo Pirro, Helmut Sinzinger, Giuseppe Schillaci, Elmo Mannarino
- Nonarrhythmic syncope documented by an implantable loop recorder (an ISSUE substudy)
- Michele Brignole, Carlo Menozzi, Angel Moya, Roberto Garcia-Civera, Paolo Donateo, Enrico Puggioni, Roberta Migliorini, Xavier Navarro, International Study on Syncope of Uncertain Etiology (ISSUE) Investigators *
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?